These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29596768)

  • 41. Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study.
    Ylikoski R; Jokinen H; Andersen P; Salonen O; Madureira S; Ferro J; Barkhof F; van der Flier W; Schmidt R; Fazekas F; Scheltens P; Waldemar G; Salvadori E; Pantoni L; Inzitari D; Erkinjuntti T;
    Dement Geriatr Cogn Disord; 2007; 24(2):73-81. PubMed ID: 17565216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a Novel Self-administered Cognitive Assessment Tool and Normative Data for Older Adults.
    Monsch RJ; Burckhardt AC; Berres M; Thomann AE; Ehrensperger MM; Steiner LA; Goettel N
    J Neurosurg Anesthesiol; 2019 Apr; 31(2):218-226. PubMed ID: 29782389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
    Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
    J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of cognitive functions in patients with multiple sclerosis applying the normative values of the Rao's brief repeatable battery in the Portuguese population.
    Sousa C; Rigueiro-Neves M; Passos AM; Ferreira A; Sá MJ;
    BMC Neurol; 2021 Apr; 21(1):170. PubMed ID: 33882847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychometric comparison of standard and computerized administration of the Alzheimer’s Disease Assessment Scale: Cognitive Subscale (ADASCog).
    O'Halloran JP; Kemp AS; Salmon DP; Tariot PN; Schneider LS
    Curr Alzheimer Res; 2011 May; 8(3):323-8. PubMed ID: 21314622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of life in patients with cognitive impairment: validation of the Quality of Life-Alzheimer's Disease scale in Portugal.
    Bárrios H; Verdelho A; Narciso S; Gonçalves-Pereira M; Logsdon R; de Mendonça A
    Int Psychogeriatr; 2013 Jul; 25(7):1085-96. PubMed ID: 23534370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing the Standard and Electronic Versions of the Alzheimer's Disease Assessment Scale - Cognitive Subscale: A Validation Study.
    Solomon TM; Barbone JM; Feaster HT; Miller DS; deBros GB; Murphy CA; Michalczuk D
    J Prev Alzheimers Dis; 2019; 6(4):237-241. PubMed ID: 31686095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adaptation and validation of the Alzheimer's Disease Assessment Scale - Cognitive (ADAS-Cog) in a low-literacy setting in sub-Saharan Africa.
    Paddick SM; Kisoli A; Mkenda S; Mbowe G; Gray WK; Dotchin C; Ogunniyi A; Kisima J; Olakehinde O; Mushi D; Walker RW
    Acta Neuropsychiatr; 2017 Aug; 29(4):244-251. PubMed ID: 28345494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved reliability of the Standardized Alzheimer's Disease Assessment Scale (SADAS) compared with the Alzheimer's Disease Assessment Scale (ADAS).
    Standish TI; Molloy DW; Bédard M; Layne EC; Murray EA; Strang D
    J Am Geriatr Soc; 1996 Jun; 44(6):712-6. PubMed ID: 8642166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive decline complaints scale (CDCS): validation and normative studies for the adults and older adults Portuguese population.
    Frias JR; Nogueira J; Gerardo B; Afonso RM; Freitas S
    Aging Ment Health; 2023 Apr; 27(4):721-728. PubMed ID: 35470707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.
    Henneges C; Reed C; Chen YF; Dell'Agnello G; Lebrec J
    J Alzheimers Dis; 2016; 52(3):1065-80. PubMed ID: 27079700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Early Mental Test--developing a screening test for mild cognitive impairment].
    Kálmán J; Pákáski M; Hoffmann I; Drótos G; Darvas G; Boda K; Bencsik T; Gyimesi A; Gulyás Z; Bálint M; Szatlóczki G; Papp E
    Ideggyogy Sz; 2013 Jan; 66(1-2):43-52. PubMed ID: 23607229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [BAC 40 battery: a tool of cognitive evaluation for the diagnosis of Alzheimer's disease at the specialist office].
    Guard O
    Rev Neurol (Paris); 2010; 166(6-7):615-20. PubMed ID: 20149920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Memory, language, and praxis in Alzheimer's disease: norms for outpatient clinical trial populations.
    Doraiswamy PM; Bieber F; Kaiser L; Connors K; Krishnan KR; Reuning-Scherer J; Gulanski B
    Psychopharmacol Bull; 1997; 33(1):123-8. PubMed ID: 9133763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment.
    Buschert VC; Giegling I; Teipel SJ; Jolk S; Hampel H; Rujescu D; Buerger K
    J Clin Psychiatry; 2012 Dec; 73(12):e1492-8. PubMed ID: 23290333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardinal features of cognitive dysfunction in Alzheimer's disease: a factor-analytic study of the Alzheimer's Disease Assessment Scale.
    Talwalker S; Overall JE; Srirama MK; Gracon SI
    J Geriatr Psychiatry Neurol; 1996 Jan; 9(1):39-46. PubMed ID: 8679062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychometric properties of the Montreal Cognitive Assessment (MoCA): an analysis using the Rasch model.
    Freitas S; Prieto G; Simões MR; Santana I
    Clin Neuropsychol; 2014; 28(1):65-83. PubMed ID: 24404822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial.
    Weyer G; Erzigkeit H; Kanowski S; Ihl R; Hadler D
    Int Psychogeriatr; 1997 Jun; 9(2):123-38. PubMed ID: 9309486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
    Suh GH; Ju YS; Yeon BK; Shah A
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlational analysis of 5 commonly used measures of cognitive functioning and mental status: an update.
    Solomon TM; deBros GB; Budson AE; Mirkovic N; Murphy CA; Solomon PR
    Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):718-22. PubMed ID: 24829061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.